Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus.
Ill effects from the condition can include fatigue, pain, neurological issues and even changes in mental health.
Initially, public health officials believed that only a small minority of people would suffer from long COVID-19. But some studies now indicate a majority of those infected with the coronavirus are experiencing long COVID-19 symptoms.
Still, estimates on the numbers of people with long COVID are all over the map.
Researchers from the Penn State College of Medicine found that more than half of COVID-19 survivors had long COVID-19.
Another study from the University of Arizona found that about 2 out of 3 people who experienced mild or moderate cases of coronavirus had long-lasting symptoms.
Other reports have been more conservative, estimating anywhere between 10 to 30 percent of those infected develop long-term symptoms. Those who experience ongoing symptoms from long COVID-19 have sometimes come to be known as COVID-19 long haulers.
One problem in figuring out how many people get long COVID-19 is defining it.
Apart from the wide range of symptoms, there is still debate over when a person is considered to have long COVID-19. Some health care authorities consider a patient to have the condition if symptoms persist after three to six weeks, while other think it should be considered on a longer basis.
Jim Heath, president and professor at the Institute for Systems Biology, is leading the Pacific Northwest consortium researching long COVID-19 as part of the National Institute of Health's (NIH) RECOVER initiative, which is looking into the post-COVID-19 condition and potential ways of preventing and treating it.
Heath told The Hill that if one definition of long COVID-19 was being used — one in which symptoms lingered about four to six weeks after infection — then roughly half of those infected would be considered to have long COVID-19.
According to Heath, an estimate of 15 to 20 percent of coronavirus survivors experiencing long COVID-19 after six months was a reasonable "educated guess" and he added that there was evidence to support that rate of occurrence.
When reached for comment by The Hill, the NIH said initial studies have found that at least half of COVID-19 patients who were hospitalized reported "persistent weakness or fatigue" months after their recovery.
Studies on the prevalence of long COVID-19 have been "relatively few," according to the NIH, and they have all focused on people who had symptomatic cases of COVID-19.
The NIH said numerous observational studies in both children and adults are being conducted to find potential treatments for long haulers. The agency has requested applications for new clinical trials to launch this summer to test potential ways of preventing and treating long COVID-19.
"In contrast to the wealth of prior knowledge that led to the vaccines for Sars-CoV-2 and a host of other viruses, there is much less known about what causes persistent symptoms following infectious illnesses or how to best treat them. As a consequence, there is more knowledge needed to fuel the scientific advances to come," the NIH said.
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
